Clinical TrialsSearch results
Number of results: 406
Completed
- RAIB-TACE for the Patients with Hepatocellular Carcinoma beyond Up-to 7 Criteria
- Hepatocellular Carcinoma
- Hoshiai Sodai
- 2021-01-29
Recruiting
- RAIB-TACE for Hepatocellular Carcinoma refractory or intolerant to Atezolizumab plus Bevacizumab
- Hepatocellular Carcinoma
- Hasegawa Naoyuki
- 2021-05-26
Other
- Quantification of Epstein-Barr virus DNA in patients undergoing SMILE chemotherapy for stage IV or relapsed/refractory extranodal NK/T-cell lymphoma
- untreated stage IV or relapsed/refractory NK/T-cell lymphoma
- NK-cell Tumor Study Group
- 2007-06-18
Recruiting
- PRT for skull base chordoma and chondrosarcoma.
- Skull base chordoma or chondrosarcoma
- Sakurai Hideyuki
- 2019-01-17
Not yet recruiting
- Providing evidence for long-term care and developing a support system for evidence-based long-term care using Long-term care Information system For Evidence (LIFE)
- A chronic condition or disability, requiring periodic, intermittent, or continuous care.
- Tamiya Nananako
- 2022-01-14
Other
- Prospective, randomized, open-label, blinded-endpoint trial to examine the effect of active vitamin D on cardiovascular events in hemodialysis patients: Japan Dialysis Active Vitamin D trial (J-DAVID)
- Chronic kidney disease stage 5D
- J-DAVID Research Group
- 2008-06-19
Other
- Prospective study of the severity-based treatment protocol for Japanese patients with MPO-ANCA-associated vasculitis
- MPO-ANCA-associated vasculitis
- Research Committe of Intractable Vasculitis Syndrome of the Ministry of Health, Labor and Welfare of Japan
- 2007-10-30
Other
- Prospective Study of hyperphosphatemia in CKD5D patients undergoing hemodialysis (STOP-HD).
- Hemodialysis patients with hyperphosphatemia
- Phosphate Research group
- 2009-05-25
Other
- Prospective Open-labelled Randomized Controlled trial for efficacy of cholesterol lowering intervention in CKD patient with dyslipidemia
- Chronic kidney disease patient with dyslipidemia
- Tokyo Medical University Ibaraki Medical Center
- 2009-03-16
Other
- Prospective multicenter clinical study evaluating efficacy and safety of Nilotinib in Ph chromosome-positive (Ph+) CML patients with Imatinib resistance or intolerance
- Chronic myelogenous leukemia
- East Japan CML Study Group (EJCML)
- 2009-07-15